Interactions between germinal center B cells and immune cells in the microenvironment can play integral roles in transformation and growth of follicular lymphoma (FL). Three recent studies, two in this issue of Cancer Cell and one in Cell Reports, elucidate how genetic alterations in CTSS and EZH2 impact these interactions, with implications for FL immunotherapy
SummaryMost B-cell lymphomas arise in the germinal center (GC), where humoral immune responses evolv...
Follicular lymphoma (FL) is an incurable form of B-cell lymphoma. Genomic alterations that inactivat...
Follicular lymphoma (FL) is an indolent disease, but 30%–40% of cases undergo histologic transformat...
The hallmark t(14;18)(q32;q21) in follicular lymphoma (FL) results in constitutive overexpression of...
Follicular lymphoma (FL) is a B-cell non-Hodgkin lymphoma of germinal center (GC) origin with a dist...
International audienceFollicular lymphomas (FLs) are slow-growing, indolent tumors containing extens...
Gain of function mutations in the H3K27 methyltransferase EZH2 represent a promising therapeutic tar...
There are important but ill-defined interactions between benign immune cell subsets and neoplastic B...
International audienceThe histone methyltransferase EZH2 has an essential role in the development of...
International audienceFollicular lymphoma (FL) results from the malignant transformation of germinal...
International audienceIt is now widely recognized that cancer development is a protracted process re...
International audienceFollicular lymphoma (FL), the most frequent indolent non-Hodgkin's B cell lymp...
Follicular lymphoma (FL) is a B cell neoplasm, composed of follicle center cells, that accounts for ...
The natural history of follicular lymphoma is heterogeneous with numerous relapses and remissions ov...
SummaryMost B-cell lymphomas arise in the germinal center (GC), where humoral immune responses evolv...
Follicular lymphoma (FL) is an incurable form of B-cell lymphoma. Genomic alterations that inactivat...
Follicular lymphoma (FL) is an indolent disease, but 30%–40% of cases undergo histologic transformat...
The hallmark t(14;18)(q32;q21) in follicular lymphoma (FL) results in constitutive overexpression of...
Follicular lymphoma (FL) is a B-cell non-Hodgkin lymphoma of germinal center (GC) origin with a dist...
International audienceFollicular lymphomas (FLs) are slow-growing, indolent tumors containing extens...
Gain of function mutations in the H3K27 methyltransferase EZH2 represent a promising therapeutic tar...
There are important but ill-defined interactions between benign immune cell subsets and neoplastic B...
International audienceThe histone methyltransferase EZH2 has an essential role in the development of...
International audienceFollicular lymphoma (FL) results from the malignant transformation of germinal...
International audienceIt is now widely recognized that cancer development is a protracted process re...
International audienceFollicular lymphoma (FL), the most frequent indolent non-Hodgkin's B cell lymp...
Follicular lymphoma (FL) is a B cell neoplasm, composed of follicle center cells, that accounts for ...
The natural history of follicular lymphoma is heterogeneous with numerous relapses and remissions ov...
SummaryMost B-cell lymphomas arise in the germinal center (GC), where humoral immune responses evolv...
Follicular lymphoma (FL) is an incurable form of B-cell lymphoma. Genomic alterations that inactivat...
Follicular lymphoma (FL) is an indolent disease, but 30%–40% of cases undergo histologic transformat...